Experience

Elucida Oncology, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chief Medical Officer

  • Oct 2020 - Present

  Setting up clinical team to develop novel drug delivery agent for multiple cancers.



OncoQuest Inc.

• Canada
• Pharmaceutical Manufacturing

• Chief Medical Officer

  • 2018 - Sep 2020

  New York, NY As member of the executive team, report directly to the CEO. Groundbreaking Clinical Study Completed preliminary negotiations with the FDA, paving the way for the innovative lead immunotherapy product to enter a large, global Phase 3 registration study in front-line ovarian cancer. Team Buildout and Management Built clinical team, inhouse and consultants to drive the above-cited global registration study. Pipeline Product Preparation Also leading the preparation… Show more As member of the executive team, report directly to the CEO. Groundbreaking Clinical Study Completed preliminary negotiations with the FDA, paving the way for the innovative lead immunotherapy product to enter a large, global Phase 3 registration study in front-line ovarian cancer. Team Buildout and Management Built clinical team, inhouse and consultants to drive the above-cited global registration study. Pipeline Product Preparation Also leading the preparation of other pipeline products for clinical study. Show less



Glenmark Pharmaceuticals

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Vice President, Clinical Sciences │ Oncology Group Buildout │ Early Clinical Development

  • 2016 - 2018

  Mahwah, NJ As the company’s business model added to its historic focus on generics, was brought in to build a new multidisciplinary oncology group to develop inhouse, novel biologics for cancer immunotherapy for early clinical development in Phase 1 studies. These included bispecific T-cell redirecting antibodies, to be followed by other cancer immunotherapies researched and manufactured at the company institute in Switzerland.



Merrimack Pharmaceuticals

• Chemical Manufacturing

• Vice President, Medical │ Clinical Trial Design │ Trial Management │ Global Regulatory Approval

  • 2011 - 2016

  Cambridge, MA Recruited as medical lead for development and implementation of registration study, regulatory submission leading to global approval of anticancer drug for pancreatic cancer. Drove early development of other novel biologic compounds and related companion diagnostics, including development strategy, design and execution of studies. Prepared and presented relative, company quarterly reports; interacted with investors and Board of Directors; and participated in select IPO activities. Unit… Show more Recruited as medical lead for development and implementation of registration study, regulatory submission leading to global approval of anticancer drug for pancreatic cancer. Drove early development of other novel biologic compounds and related companion diagnostics, including development strategy, design and execution of studies. Prepared and presented relative, company quarterly reports; interacted with investors and Board of Directors; and participated in select IPO activities. Unit Buildout Supported formation of commercial unit and initiated and built out biometrics and safety units. Team Leadership Directed activities of entire team of multidisciplinary experts, while the company grew from 150 to 250, ensuring creation of a high-quality infrastructure to produce reliable results. Show less



Johnson & Johnson

• Law Practice
• 1 - 100 Employee

• Vice President, Medical Affairs, Cellular Technologies (Veridex/Therakos), Ortho Clinical Diagnostic

  • 2010 - 2011

  Raritan, NJ As member of the Cellular Technologies Global Management team, collaborated closely with franchise clinical and commercial teams to drive growth of oncology-related devices and diagnostics. Oversaw field-based medical science liaisons team, built and maintained relationships with customers. Contributed to pharmacovigilance, copy review and healthcare compliance activities. Program Leadership Provided strategic input and directed medical education and investigator-initiated studies… Show more As member of the Cellular Technologies Global Management team, collaborated closely with franchise clinical and commercial teams to drive growth of oncology-related devices and diagnostics. Oversaw field-based medical science liaisons team, built and maintained relationships with customers. Contributed to pharmacovigilance, copy review and healthcare compliance activities. Program Leadership Provided strategic input and directed medical education and investigator-initiated studies programs in support of Veridex CellSearch® (circulating tumor cells) and Therakos (extracorporeal photopheresis) products. Clinical Focus Guided clinical direction to two diverse marketed products, one a diagnostic apparatus the other a treatment device, in a medical affairs capacity.

• Senior Director| Clinical Team Leader, Oncology, Ortho-Biotech, Oncology Research

  • 2005 - 2010

  Raritan, NJ Served as global clinical leader for Yondelis® and Doxil®, guiding progression from clinical development to life cycle management, including management of a large Expanded Access Program. Also participated in early development of new targeted oncology products. Regulatory Submission Led regulatory submission for treatment of ovarian cancer to the FDA, including presentation at the associated ODAC, and the EMA. Cell Therapy JV Member of joint development team to investigate… Show more Served as global clinical leader for Yondelis® and Doxil®, guiding progression from clinical development to life cycle management, including management of a large Expanded Access Program. Also participated in early development of new targeted oncology products. Regulatory Submission Led regulatory submission for treatment of ovarian cancer to the FDA, including presentation at the associated ODAC, and the EMA. Cell Therapy JV Member of joint development team to investigate cell therapy as a joint venture with the National Cancer Institute and promote cross-sector development of other oncology-related products. Due Diligence Participated in “due diligence” for in- and out-licensing. Collaborations Facilitated ongoing development of strategic partnerships, to improve efficiency of drug development.



Wyeth Research

• Senior Director, Medical Research, Oncology

  • 2003 - 2005

  Cambridge, MA



Human Genome Sciences

• United States
• Biotechnology
• 400 - 500 Employee

• Director, Clinical Research

  • 2000 - 2002

  Rockville, MD



Bayer Pharmaceuticals

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Director, Anti-Infectives/Biologicals, Medical Research

  • 1999 - 2000

  West Haven, CT



Children’s National Medical Center │ Washington Hospital Center

• Prior Experience

  • 1995 - 1998

  Director, Hematopoietic Stem Cell Transplantation; Program Senior Investigator, Center for Cancer and Transplantation; Biology Member, Institutional Biosafety Committee, Children’s National Medical Center, Washington, DC (1995 – 1998) Attending Physician, Department of Medicine; Scientific Director, Stem Cell Transplantation, Washington Hospital Center, Washington, DC (1995-1998)